✦ LIBER ✦

Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent

✍ Scribed by Ritu Aneja; Neerupma Dhiman; Jyoti Idnani; Anshumali Awasthi; Sudershan K. Arora; Ramesh Chandra; Harish C. Joshi

Publisher: Springer
Year: 2007
Tongue: English
Weight: 328 KB
Volume: 60
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-007-0430-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative bioavailability and pharmaco

Comparative bioavailability and pharmacokinetics of noscapine hydrogen embonate and noscapine hydrochloride

✍ V. Haikala; A. Sothmann; M. Marvola 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 298 KB

Preclinical pharmacokinetics of β-L-diox

Preclinical pharmacokinetics of β-L-dioxolane-cytidine, a novel anticancer agent, in rats

✍ Laura E. Moore; F. D. Boudinot; Chung K. Chu 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 198 KB

Pharmacokinetics and distribution of SN

Pharmacokinetics and distribution of SN 28049, a novel DNA binding anticancer agent, in mice

✍ Pradeep B. Lukka; James W. Paxton; Philip Kestell; Bruce C. Baguley 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 336 KB

Pharmacokinetics and bioavailability of

Pharmacokinetics and bioavailability of the anti-emetic agent bromopride

✍ R. R. Brodie; L. F. Chasseaud; A. Darragh; R. F. Lambe; L. Rooney; T. Taylor 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 1 views

The pharmacokinetics of bromopride, an anti-emetic agent chemically related to metoclopramide, has been investigated in normal human subjects. After intravenous bolus doses of lOmg, a one-compartment open model appeared adequate to describe the plasma drug concentration data. The systemic clearance

Preclinical pharmacokinetics and oral bi

Preclinical pharmacokinetics and oral bioavailability of BMS-310705, a novel epothilone B analog

✍ Amrita V. Kamath; Ming Chang; Francis Y. Lee; Yueping Zhang; Punit H. Marathe 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 314 KB

Bioavailability and pharmacokinetics of

Bioavailability and pharmacokinetics of the investigational anticancer agent XK469 (NSC 698215) in rats following oral and intravenous administration

✍ Ramesh R. Boinpally; Sen-Lin Zhou; Patricia M. LoRusso; Ralph E. Parchment 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 239 KB